Polio vaccine

Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use

Posted by

0


On June 22, 2022, the UK Health Security Agency announced that vaccine-derived poliovirus type 2 (VDPV2) had been repeatedly detected in sewage in London, UK.

 Several weeks later, the New York State Department of Health reported a case of acute flaccid paralysis caused by VDPV2 in an unvaccinated individual; the first case of poliomyelitis in almost a decade in the USA.

2

 A similar virus has also been detected in sewage from Jerusalem, Israel.

3

These events herald an unexpected and concerning development in the fight against polio; they demonstrate that vaccine-derived polioviruses (VDPVs) can emerge in high-income settings with good sanitation where the live oral polio vaccine (OPV) is not in use. Moreover, these incidents indicate that VDPV2 transmission might be more widespread than is currently understood, risking further cases of paralytic disease among undervaccinated individuals. There is limited precedent for responding to VDPV2 transmission in these settings, and thus the impact of all interventions made by the UK and USA must be closely evaluated.

VDPVs are not a new phenomenon. It is well recognised that the live, highly attenuated poliovirus strains (Sabin 1, 2, and 3), which constitute the trivalent OPV can, on occasion, mutate sufficiently to regain virulence and cause outbreaks of poliomyelitis.

4

 Although genetic reversion to generate circulating VDPVs (cVDPVs) is infrequent, it occurs more readily in settings of persistently low immunisation coverage, where extensive viral replication and person-to-person transmission are possible.

4

 In recent years, there has been a marked increase in cVDPV outbreaks and resultant cases of paralytic poliomyelitis in susceptible individuals. In 2020, there were 1113 cases of poliomyelitis caused by cVDPVs across 27 countries, compared with 140 wild poliovirus type 1 cases limited to Afghanistan and Pakistan; this represented the highest total number of poliomyelitis cases in over a decade.

5

 The majority of cVDPV strains have evolved from the Sabin 2 virus, and thus are designated as cVDPV2.

The rise in the number and scale of cVDPV2 outbreaks over the past 4 years is multifactorial. In 2016, there was a synchronised global withdrawal of Sabin 2-containing trivalent OPV, and a switch to bivalent OPV (Sabin 1 and 3) in countries using the OPV, designed to limit the emergence of further VDPV2 strains and eliminate the risk of vaccine-associated paralytic poliomyelitis caused by Sabin 2.

6

 Although most countries eliminated Sabin-like poliovirus type 2 (SL2) transmission following the switch, some cVDPV2 transmission continued, leading to sporadic cVDPV2 outbreaks as poliovirus type 2 mucosal immunity declined.

7

,  

8

 Sabin monovalent OPV type 2 (mOPV2) was used to address these outbreaks, but many such campaigns were delayed and provided insufficient coverage, leading to further emergence and transmission of cVDPV2.

8

,  

9

 The COVID-19 pandemic compounded the issue; routine polio vaccination, surveillance, and cVDPV2 outbreak response activities were suspended for 4 months in 2020 to protect communities and health workers, enabling further spread of cVDPV2.

8

 Furthermore, many of the large cVDPV2 outbreaks have emerged in countries such as Afghanistan, which are beset by conflict, with highly mobile populations and inadequate health infrastructures.

The discovery of VDPV2 in London and New York (NY, USA) should come as a wake-up call. As the full extent of VDPV2 transmission in these cities is evaluated, the factors underlying such transmission in settings with exclusive inactivated polio vaccine (IPV) use, high national vaccine coverage, and good sanitation must also be fully assessed.

A possible explanation would be that VDPV2 has emerged following shedding and subsequent circulation of SL2 by individuals who were vaccinated overseas with Sabin mOPV2, and ongoing VDPV2 transmission is occurring in undervaccinated communities. Rockland (NY, USA), the county where a case of poliovirus has been identified, has routine childhood immunisation coverage of 42%, the lowest in New York,

10

 and inactivated polio vaccine vaccination coverage in London has fallen in recent years, with coverage as low as 73·6% in some boroughs.

11

 However, the finding of virus in sewage over several months from a large population and with high genetic diversity of the isolated viruses implies that transmission could be widespread.

12

The USA and the UK have exclusively used IPV since 2000 and 2004, respectively.

13

,  

14

 Although two or more doses of IPV provide excellent humoral immunity, protecting fully-vaccinated individuals from developing poliomyelitis caused by all strains of poliovirus, including VDPV2, IPV is less effective than OPV at inducing intestinal mucosal immunity, meaning IPV-vaccinated individuals might theoretically be able to shed polioviruses in their stool, facilitating transmission.

15

,  

16

 However, there are currently few real-world data to evidence this, and the previous success of the IPV in eliminating polio in the Netherlands and Scandinavian countries suggests that a more complex picture of poliovirus immunity and VDPV2 transmission in London and New York might emerge.

17

,  

18

There is evolving evidence of genetic linkages between the polioviruses detected in London and New York, and also with SL2 viruses identified in sewage from Jerusalem in June, 2022.

3

 Israel boasts high vaccination coverage with both the IPV and bivalent OPV (97·6% and 88·3% for the IPV and bivalent OPV, respectively), but despite this, has also recently identified circulating vaccine-derived poliovirus type 3, with one case of poliomyelitis occurring on March 7, 2022.

19

The rise in VDPV2 transmission presents a conundrum for global polio eradication. Eradication of both wild polioviruses and VDPVs is dependent on complete interruption of transmission; this is assumed to be conditional on induction of robust mucosal immunity through use of the OPV. However, VDPV interruption cannot be completed until OPV use is ceased. A potential solution to this dilemma is the development of more genetically stable oral poliovirus vaccine strains, which are less likely to evolve into VDPVs. Indeed, in 2020, a novel OPV-2 (nOPV2) vaccine was granted Emergency Use Listing status by WHO and has since been used extensively in cVDPV2 outbreak settings, with surveillance data indicating a high likelihood of success without the same risk of emergence of cVDPV2 as with standard OPV.

20

,  

21

Both London and New York represent very different settings to those where nOPV2 is currently being deployed, with regard to both coverage and type of polio immunity, sanitation standards, and surveillance systems. It is, therefore, conceivable that alternative strategies could be sufficient to interrupt VDPV2 transmission and prevent cases of poliomyelitis in these settings. Intensified surveillance, catch-up IPV immunisation programmes with prioritisation of unvaccinated individuals, and IPV booster programmes might all have a part to play. However, there is limited precedent for the management of VDPV2 transmission in IPV-only vaccinated populations, and although there is promise with options such as nOPV2, the dynamics of response strategies in these settings remain to be fully evaluated.

Ultimately, the isolation of VDPV2 in both the UK and USA in recent weeks mandates three urgent interventions. First, poliovirus surveillance is needed in affected countries and more broadly in countries without any surveillance to understand the extent of VDPV2 transmission worldwide and to mount timely and appropriate responses. Second, an urgent emphasis must be placed on improving vaccination coverage; while polioviruses remain in circulation, all unvaccinated and undervaccinated individuals remain at risk of this paralysing disease, and inadequately immunised populations could be contributing to ongoing transmission in communities. Third, evaluation of interventions is needed to assess the extent to which improving coverage of the unvaccinated, using catch-up doses for the undervaccinated, giving extra booster doses in wider populations, or aligning regulatory and operational preparedness for use of live oral vaccines (such as the nOPV2) are needed to control these new and unexpected outbreaks. Building momentum to adequately fund the implementation of the Polio Eradication 2022–26 strategy will be key to permanently stopping polio transmission and the risk of paralysis everywhere.

22

 Failure to get this right threatens the global progress towards polio eradication.

Source: The Lancet

The Polio Vaccine Doesn’t Stop Polio

Posted by

0


While we’re on the topic of Vaccines in the CDC Schedule that Don’t Stop Transmission of the Disease They’re Named After, now would be a good time to stop saying “because polio” as justification for mandating every vaccine that comes to market.

I hate to burst your bubble (not really– I love it so much that I write this ish for free) but the Enhanced-Potency Inactivated Polio Vaccine (IPV) that replaced the Oral Polio Vaccine (OPV) in 1999 doesn’t prevent transmitting polio.  It’s been 17 years since we’ve used a polio-transmission-reduction vaccine in the US so if your kid is in high school or younger, they didn’t get a real polio vaccine, and they’re not protected from contracting polio.

In 1999 the Advisory Committee on Immunization Practices voted to completely replace OPV with IPV in order to “eliminate the risk of vaccine-associated paralytic poliomyelitis.” That’s a fancy way of admitting that the oral vaccine was the only cause of polio in America.  See, the OPV was pretty good at preventing polio infection except when it caused polio in the person who received the vaccine, and then that person gave polio to a bunch of other people.

As far as the vaccine vs. improved sanitation argument goes, even the CDC admits that before the vaccine was available, improved sanitation was to thank for reduced exposure to the virus.  Clean water and indoor plumbing were great for reducing initial polio infections but just like with chickenpox/shingles, the eradication of the “booster” that previously-infected people were getting from natural re-exposure was causing epidemics.

Even the Polio Global Eradication Initiative admits that the IPV “does not stop transmission of the virus.”  They go on to say that “when a person immunized with IPV is infected with wild poliovirus, the virus can still multiply inside the intestines and be shed in the feces, risking continued circulation.”  Get your polio vaccine, still catch polio, still give polio to the community.

So what’s it good for then?  The current polio vaccine claims to be good at preventing the vaccinated person from developing severe polio symptoms.  That’s it.  You’re  allegedly spared an iron lung but you aren’t contributing to any “community immunity” by vaccinating your child for polio grown in (you can trust them this time, it’s perfectly safe) monkey kidney cells.

Again, it’s their own personal seat belt in the event of an accident.  Infants and toddlers can contract polio, grow a polio infection in their intestines, shed it in their bowel movements, and expose everyone who comes into contact with their diapers to wild polio. Which, thankfully we don’t have much of in this country and if we do, we make sure we call it by a different name.

I haven’t actually found any studies that show the efficacy of the post-1978 Enhanced-Potency IPV in preventing paralysis but feel free to leave a link in the comments if you know of one.  The CDC’s pink book doesn’t claim any studies— it only says that the presence of antibodies correlates with protection against paralysis.

Wait, what was that saying about correlation and causation?  Or is that expression only valid when used against parents of the vaccine injured?

The CDC also says they don’t know how long this supposed immunity lasts, but it’s “probably” a lifetime.  Thanks for being so thorough, CDC.

Maybe you’re thinking that protecting your child from polio paralysis is the only reason you need to get the IPV and I totally understand your thinking. But you should know that 95% of all polio is symptom-free while paralytic polio happens less than 1% of the time.

By no means am I arguing for the return of the use of OPV in American children. India has been making headlines in recent years with its skyrocketing rate of “non-polio acute flaccid paralysis” that is strongly associated with the oral polio vaccine administered during their polio elimination campaign.  India was declared polio-free in January 2011 while over 137,000 of her people suffered post-vaccine paralysis as collateral damage in just 2 1/2 years.  Plus there’s the added bonus that people vaccinated with the OPV will shed polio in their bowel movements, which in developing countries are often deposited alongside the road, which then give polio to people who come in contact with it.

Sanitation is everything, isn’t it?  Maybe we should give a little less gratitude to pharmaceutical companies and a lot more thanks to plumbers.

The Polio Vaccine Cancer Cover-up

Posted by

1


Polio-Vaccine-new-title

The polio vaccines developed in the 1950s by Jonas Salk and Albert Sabin allegedly eradicated one of the most feared diseases of the 20th century. The media hailed the success of these vaccines as a modern day miracle. However, the polio story has a much darker side that has mostly been kept a secret.

Both Sabin’s live virus vaccine given orally and Salk’s inactivated virus vaccine given by injection were far from perfect. In fact, in 1955 the vaccine used in Berkley, California infected some 200 children, leaving several dead and many paralyzed. Yet this incident proved minor compared to what was later discovered.

In order to grow large quantities of the poliovirus, scientists needed to use Rhesus monkey kidney cells, which carried many different viruses. As a result, their polio vaccine became contaminated with a cancer-causing virus carried by these monkeys. This vaccine was given to almost 100 million people.

The virus found in this particular polio vaccine was SV40, or simian virus. It is present in human tumors, and research has established it to be a contributing factor in the rise of many types of cancer, including mesothelioma, bone, and brain cancer.

When the government became aware of this, it was downplayed for fear the public would stop accepting vaccination.

WHO gives 2 weeks to replace problem polio vaccine

Posted by

0


The World Health Organization today gave countries two weeks to replace a problem polio vaccine blamed for some outbreaks of the crippling disease, which the UN health agency is hoping to wipe out once and for all.
WHO has warned that the live polio virus used in some vaccines is one of the biggest obstacles to eradicating the disease.
For the past year and a half, 155 countries and territories have been gearing up to make the shift away from the problem vaccine, with the big switch set to begin on Sunday and to be completed by May 1, WHO said.
“The switch is a significant milestone in the effort to achieve a polio-free world,” WHO said in a statement.
A massive global effort has in recent decades come close to wiping out polio, a crippling and potentially fatal viral disease that mainly affects children under the age of five.
Cases have decreased by 99 per cent since 1988, when polio was endemic in 125 countries and 350,000 cases were recorded worldwide.
The wild version of the virus now exists only in Afghanistan and Pakistan, but a type of vaccine that contains small amounts of weakened but live polio still causes occasional outbreaks elsewhere.
Oral polio vaccine (OPV) replicates in the gut and can be passed to others through faecal-contaminated water — meaning it won’t hurt the child who has been vaccinated, but could infect their neighbours.
Long-term, WHO recommends that the OPV should be phased out worldwide and replaced by the inactivated polio vaccine (IPV).
But due to a range of constraints, including shortages of supply, the shift is expected to take a while.
In the meantime, the WHO Strategic Advisory Group of Experts, which advises the agency on immunisation, has called for the withdrawal of one form of OPV considered to be at the root of the problem.
The trivalent vaccine protects against all three types of polio, including type 2, which no longer exists in the wild but which causes most vaccine-derived outbreaks.
By the end of this month, countries will simultaneously swap out that vaccine with the bivalent version of OPV, which only protects against polio types 1 and 3.
Since the problem vaccine contains a small dose of type 2 polio, the switch needs to be coordinated to prevent outbreaks in places where the trivalent vaccine is no longer being used.
When the switch is done, “approximately 300 million doses of bivalent OPV will be used in routine immunisation programmes around the world” annually, WHO spokesman Oliver Rosenbauer told AFP.

Polio vaccines causing worldwide surge in childhood paralysis cases

Posted by

0


In April 2012, Aaron Dykes of Truthstream Media reported that statistically speaking, polio had been eradicated in India, but the statistics don’t tell the whole story.

In fact, he noted, there was a spike in “non-polio acute flaccid paralysis (NPAFP) – the very types of crippling problems it was hoped would disappear with polio but which have instead flourished from a new cause.” How could that happen in a nation where polio had ostensibly been eradicated?

Quite simply, Dykes noted, the new spike was actually coming from the oral polio vaccine.

He further reported:

There were 47,500 cases of non-polio paralysis reported in 2011, the same year India was declared “polio-free,” according to [Dr. Neetu Vashisht and Dr. Jacob Puliyel of the Department of Paediatrics at St Stephens Hospital in Delhi]. Further, the available data shows that the incidents tracked back to areas were doses of the polio vaccine were frequently administered. The national rate of NPAFP in India is 25-35 times the international average.

Cases are spreading

Dykes further reported that it had been established that vaccines were causing the uptick in vaccine-associated polio paralysis (VAPP).

Now, he says, cases are occurring in other countries. The Washington Post noted that cases of polio paralysis have cropped up in Ukraine, which is involved in a bitter conflict with Russia-backed separatists in the eastern portion of the country.

The Washington Post reported that the World Health Organization said the small outbreak, which has affected just two children thus far, is directly attributable to the vaccine:

cVDPV is a rare, mutated form of the virus that comes from the vaccine itself. Oral polio vaccines contain a weakened form of the virus that activates an immune response in the body so that it builds up antibodies to protect itself. But it takes some time for this to happen, and meanwhile the virus replicates in the intestines and can be excreted by the person immunized and can spread to others in the community.

Dykes reports that new outbreaks are still occurring in India as well as Madagascar and South Sudan, according to the WHO.

“In South Sudan, 2 cases due to cVDPV type 2 (cVDPV2) have been confirmed. The strains were isolated from 2 acute flaccid paralysis (AFP) cases in Unity state, with onset of paralysis on 9 September and 12 September 2014, respectively,” the WHO reported in a press release.

“In Madagascar, cVDPV type 1 (cVDPV1) has been confirmed after the virus was isolated from 1 case of AFP (onset of paralysis on 29 September 2014) and 3 healthy contacts.”

Dykes says that the truly alarming thing is that oral polio vaccines of the type still being distributed by WHO and supported by the Bill and Melinda Gates Foundation were discontinued in the West some 15 years ago for the same reason: WHO and other health officials knew that it was causing VAPP!

Did Bill Gates know?

“They know that this vaccine will – statistically anyway – harm some children and could potentially spawn outbreaks, but they use it anyway, supposedly because less developed regions are not equipped to handle refrigerated vaccines that don’t contain the live virus,” he wrote.

Truthstream Media has been tracking the rising incidents of vaccine-caused polio for years. In 2013, the site questioned whether billionaire Microsoft founder Bill Gates knew his polio vaccine push through his foundation would actually harm the very children he claimed to be trying to help:

The Bill and Melinda Gates Foundation created the GAVI alliance to push vaccinations on the poorest parts of the developing world in the name of “saving lives” and stopping disease.

In particular, Bill Gates expects to take credit for wiping out polio worldwide by making it one of his primary issues. But at what cost?

If Gates didn’t know, Dykes wrote, he “certainly OUGHT to have” known.

Learn more: http://www.naturalnews.com/051247_polio_vaccines_paralysis_India.html#ixzz3mLqAik7D

Polio Virus in Syria and Israel May Endanger Europe.

Posted by

0


Two infectious disease experts warn that a new polio outbreak in Syria caused by wild-type polio virus 1 (WPV1) and asymptomatic cases in Israel might endanger Europe and other neighboring regions, according to correspondence published online November 8 in the Lancet.

“[The World Health Organization] has confirmed an outbreak of at least ten cases of polio in Syria, where vaccination coverage has dramatically decreased during the civil war,” write Professor Martin Eichner, from the Institute of Clinical Epidemiology and Applied Biometry, University of Tübingen, and Stefan Brockmann, from the Department for Infection Control, Reutlingen Regional Public Health Office, Germany. “Furthermore, [WPV1] has been isolated from sewage and faeces from asymptomatic carriers in Israel since February, 2013.

“Moreover, hundreds of thousands of people are fleeing Syria and seek refuge in neighbouring countries and Europe,” they continue. During the Hajj in Saudi Arabia last month, visitors from countries with known polio transmission were vaccinated, but Syria was not included with those countries.

“The potential risk of transmission to [the European Union (EU)] and elsewhere documents the need for strong ongoing global efforts to eradicate this disease,” CDC Director Tom Frieden, MD, MPH, told Medscape Medical News. “Polio anywhere is a threat of polio everywhere.”

The situation in the Middle East, combined with the vaccination approach used in Europe, is concerning, according to the authors. Most EU countries currently use inactivated polio vaccine (IPV) rather than oral polio vaccination (OPV). Similar to many other regions, most EU states discontinued use of OPV because of rare reports that it caused acute flaccid paralysis (AFP), even though OPV offers high protection against acquiring and transmitting the infection. Only some EU member states still permit OPV use, and none has a stockpile of it.

In contrast, the more widely used IPV is highly effective in preventing AFP and active polio disease, but is only partially effective in preventing infection with polio virus. For decades, Europe has been free of circulating polio viruses and, therefore, IPV has been sufficient.

However, IPV will only continue to be effective in preventing transmission if vaccination coverage continues to be very high, if hygienic standards are good throughout the population, and if there is low crowding. These conditions could easily be disrupted by the present situation of large numbers of refugees fleeing from Syria to Europe and other neighboring countries.

If the polio virus is reintroduced into the community, herd immunity may be insufficient to prevent sustained transmission in European regions where vaccination coverage is low, such as Bosnia and Herzegovina (87%), Ukraine (74%), and Austria (IPV coverage rate 83%).

For every 200 WPV1 infections, only 1 results in symptomatic polio. Therefore, hundreds of individuals could be infected and the virus could circulate for nearly a year before an outbreak could be identified from a single case of AFP.

“Vaccinating only Syrian refugees — as has been recommended by the European Centre for Disease Prevention and Control — must be judged as insufficient; more comprehensive measures should be taken into consideration;” the authors conclude. “Routine screening of sewage for poliovirus has not been done in most European countries, but this intensified surveillance measure should be considered for settlements with large numbers of Syrian refugees.”

Implications for the United States

In the United States, routine vaccination against polio currently uses IPV, which may create concerns similar to those now affecting Europe.

“The IPV vaccine is effective at preventing disease, but [OPV] is more effective at preventing even asymptomatic infection,” Jennifer L. Lyons, MD, from the Division of Neurological Infections, Department of Neurology, Brigham and Women’s Hospital in Boston, Massachusetts, told Medscape Medical News. “However, the OPV has been associated with a low but known risk of vaccine-related infection and, as such, is no longer routinely used.”

“It is difficult to project the effect that this scenario will have on the US, but vigilance is always good practice,” Dr. Lyons said. “Adherence to vaccination guidelines and maintenance of proper hygiene are likely the best preventive measures to take.”

Dr. Frieden told Medscape Medical News that IPV is used in Israel, as well as in the EU and the United States. “There have been no cases of indigenous polio in these regions, an especially significant fact considering that poliovirus has been found in environmental sewage samples in Israel,” Dr. Frieden said. “IPV is effective in protecting individuals against polio. The US has been free of indigenous polio since 1979.”

He also noted that the risk of importations of any infectious disease, including polio, into the United States is always a concern and highlights the importance of being vaccinated and of working to control infectious diseases wherever they are spreading.

“CDC works to minimize the risk for polio in the US through its traveler’s health and global migration program and global health program,” Dr. Frieden concluded. “We collaborate closely with international organizations and other countries to implement international and US guidance on vaccination for immigrants. In response to the polio cases in the Middle East and Horn of Africa, CDC has issued new recommendations for polio vaccine use among high-risk refugee populations and is working with international partners to implement them. Through the Global Polio Eradication Initiative, CDC works intensively with international health partners and Rotary International to eradicate polio at its source.”

If Your Doctor Insists That Vaccines Are Safe, Then Have Them Sign This Form.

Posted by

0


vac

The average person that consents to a vaccine injection, either for themselves or for their children, genuinely believes it is for the betterment of health. What they are not aware of is that even their doctor is likely unfamiliar with the toxic ingredients contained in vaccines which can immediately begin to degrade both short- and long-term health. If your doctor insists that vaccines are safe, then they should have absolutely no problem in signing this form so that you may archive it for your own records on the event of an adverse reaction.

 

The reality of vaccines is that they are a far greater risk to human health than benefit and always have been. In fact, two centuries of official death statistics show conclusively and scientifically that modern medicine is not responsible for and played little part in substantially improving life expectancy and survival from diseases in developed nations.

In North America, Europe, and the South Pacific, major declines in life-threatening infectious diseases occurred historically either without, or far in advance vaccination efforts for specific diseases.

Whenever I personally inform medical doctors of these realities, many of them are quite shocked with the data. That’s not surprising considering the fact that medical students are still brainwashed that vaccines immunize which is a myth in itself, since natural or “real” immunity can never be artificially induced by a vaccine.

Other misinformed educators also still rely on the myth of herd immunity which is nothing short of medical fraud. It is a shame and embarrassment that brilliant students are deceptively led down the path of ignorance every single year at prestigious medical institutions in the hopes of obtaining an education. These students then become the physicians of a good percentage of the population.

One of the problems we have in a society filled with misinformation about health, is that people sit on the fence. They want to conform to the societal norms ingrained in our minds about conventional medicine, but they also want to stand up for their beliefs and conscience. These fence sitters are made up of those who understand that current vaccination practices are unsafe, yet somehow also believe you can make vaccines safer or more effective. That is where we have to shift the opinions of those who are on the fence and have them fall off on the side of natural health rather than conventional medicine. See my article When It Comes to Vaccines, Don’t Sit On The Fence!

I have previously written that if your doctor cannot answer these 4 questions, don’t vaccinate. Well, if your doctor does make an attempt to answer these questions and a verbal response and statement is not satisfactory for your own peace of mind, then your doctor should be at least willing to provide you with his or her personal declaration of the safety and efficacy of the vaccines he or she (or attending physician or nurse) is about to inject in your or your child’s body. Effectively, this becomes your doctor’s warranty that the risk factors he or she has identified justify the recommended vaccinations with the benefits exceeding the risks.

 

Physician’s Warranty of Vaccine Safety Form

The following form was adapted from Ken Anderson’s original. Perhaps you can find a physician that will sign it because I have no record of that ever happening:

PHYSICIAN’S WARRANTY OF VACCINE SAFETYI (Physician’s name, degree)_______________, _____ am a physician licensed to practice medicine in the State/Province of _________. My State/Provincial license number is ___________ , and my DEA number is ____________. My medical specialty is _______________I have a thorough understanding of the risks and benefits of all the medications that I prescribe for or administer to my patients. In the case of (Patient’s name) ______________ , age _____ , whom I have examined, I find that certain risk factors exist that justify the recommended vaccinations. The following is a list of said risk factors and the vaccinations that will protect against them:
Risk Factor __________________________
Vaccination __________________________
Risk Factor __________________________
Vaccination __________________________
Risk Factor __________________________
Vaccination __________________________I am aware that vaccines may contain many of the following chemicals, excipients, preservatives and fillers:

* aluminum hydroxide
* aluminum phosphate
* ammonium sulfate
* amphotericin B
* animal tissues: pig blood, horse blood, rabbit brain,
* arginine hydrochloride
* dog kidney, monkey kidney,
* dibasic potassium phosphate
* chick embryo, chicken egg, duck egg
* calf (bovine) serum
* betapropiolactone
* fetal bovine serum
* formaldehyde
* formalin
* gelatin
* gentamicin sulfate
* glycerol
* human diploid cells (originating from human aborted fetal tissue)
* hydrocortisone
* hydrolized gelatin
* mercury thimerosol (thimerosal, Merthiolate(r))
* monosodium glutamate (MSG)
* monobasic potassium phosphate
* neomycin
* neomycin sulfate
* nonylphenol ethoxylate
* octylphenol ethoxylate
* octoxynol 10
* phenol red indicator
* phenoxyethanol (antifreeze)
* potassium chloride
* potassium diphosphate
* potassium monophosphate
* polymyxin B
* polysorbate 20
* polysorbate 80
* porcine (pig) pancreatic hydrolysate of casein
* residual MRC5 proteins
* sodium deoxycholate
* sorbitol
* thimerosal
* tri(n)butylphosphate,
* VERO cells, a continuous line of monkey kidney cells, and
* washed sheep red blood

and, hereby, warrant that these ingredients are safe for injection into the body of my patient. I have researched reports to the contrary, such as reports that mercury thimerosal causes severe neurological and immunological damage, and find that they are not credible.

I am aware that some vaccines have been found to have been contaminated with Simian Virus 40 (SV 40) and that SV 40 is causally linked by some researchers to non-Hodgkin’s lymphoma and mesotheliomas in humans as well as in experimental animals. I hereby warrant that the vaccines I employ in my practice do not contain SV 40 or any other live viruses. (Alternately, I hereby warrant that said SV-40 virus or other viruses pose no substantive risk to my patient.)

I hereby warrant that the vaccines I am recommending for the care of (Patient’s name) _______________ do not contain any tissue from aborted human babies (also known as “fetuses”).

In order to protect my patient’s well being, I have taken the following steps to guarantee that the vaccines I will use will contain no damaging contaminants.

STEPS TAKEN: _________________________
_______________________________________
_______________________________________
_______________________________________

I have personally investigated the reports made to the VAERS (Vaccine Adverse Event Reporting System) and state that it is my professional opinion that the vaccines I am recommending are safe for administration to a child under the age of 5 years.

The bases for my opinion are itemized on Exhibit A, attached hereto, — “Physician’s Bases for Professional Opinion of Vaccine Safety.” (Please itemize each recommended vaccine separately along with the bases for arriving at the conclusion that the vaccine is safe for administration to a child under the age of 5 years.)

The professional journal articles I have relied upon in the issuance of this Physician’s Warranty of Vaccine Safety are itemized on Exhibit B , attached hereto, — “Scientific Articles in Support of Physician’s Warranty of Vaccine Safety.”

The professional journal articles that I have read which contain opinions adverse to my opinion are itemized on Exhibit C , attached hereto, — “Scientific Articles Contrary to Physician’s Opinion of Vaccine Safety”

The reasons for my determining that the articles in Exhibit C were invalid are delineated in Attachment D , attached hereto, — “Physician’s Reasons for Determining the Invalidity of Adverse Scientific Opinions.”

Hepatitis B

I understand that 60 percent of patients who are vaccinated for Hepatitis B will lose detectable antibodies to Hepatitis B within 12 years. I understand that in 1996 only 54 cases of Hepatitis B were reported to the CDC in the 0-1 year age group. I understand that in the VAERS, there were 1,080 total reports of adverse reactions from Hepatitis B vaccine in 1996 in the 0-1 year age group, with 47 deaths reported.

I understand that 50 percent of patients who contract Hepatitis B develop no symptoms after exposure. I understand that 30 percent will develop only flu-like symptoms and will have lifetime immunity. I understand that 20 percent will develop the symptoms of the disease, but that 95 percent will fully recover and have lifetime immunity.

I understand that 5 percent of the patients who are exposed to Hepatitis B will become chronic carriers of the disease. I understand that 75 percent of the chronic carriers will live with an asymptomatic infection and that only 25 percent of the chronic carriers will develop chronic liver disease or liver cancer, 10-30 years after the acute infection. The following scientific studies have been performed to demonstrate the safety of the Hepatitis B vaccine in children under the age of 5 years.
____________________________________
____________________________________ _____________________________________

In addition to the recommended vaccinations as protections against the above cited risk factors, I have recommended other non-vaccine measures to protect the health of my patient and have enumerated said non-vaccine measures on Exhibit D , attached hereto, “Non-vaccine Measures to Protect Against Risk Factors” I am issuing this Physician’s Warranty of Vaccine Safety in my professional capacity as the attending physician to (Patient’s name) ________________________________. Regardless of the legal entity under which I normally practice medicine, I am issuing this statement in both my business and individual capacities and hereby waive any statutory, Common Law, Constitutional, UCC, international treaty, and any other legal immunities from liability lawsuits in the instant case. I issue this document of my own free will after consultation with competent legal counsel whose name is _____________________________, an attorney admitted to the Bar in the State of __________________ .
_________________________ (Name of Attending Physician)
______________________ L.S. (Signature of Attending Physician)
Signed on this _______ day of ______________ A.D. ________
Witness: _________________ Date: _____________________
Notary Public: _____________Date: ______________________

Source: http://www.realfarmacy.com

 

2018 must be the final target for polio eradication.

Posted by

1


Since the eradication of smallpox in the late 1970s, no other diseases have followed suit; the goal that has come closest so far is eradication of polio. The development of vaccines in the 1950s led to cases of polio plummeting: whereas hundreds of thousands were affected annually in the middle of last century, in 2012 around 250 people were paralysed by the disease. But the final stages of eradication are proving more difficult than the early phases. The disease remains entrenched in three countries—Afghanistan, Nigeria, and Pakistan—where social, political, and logistical factors prevent effective vaccination campaigns and lead to export of virus to countries that have previously been free of the disease.

As Haris Riaz and Anis Rehman reported in the journal last month, the global polio eradication programme suffered a grave setback in December last year when seven vaccination workers were shot dead by terrorists as they took part in a 3 day campaign to deliver vaccine in Karachi and Peshawar. At the end of January, two more vaccine workers were killed in a landmine explosion in the Kurrum tribal region. These two latest casualties are not thought to have been directly targeted, but unwitting victims of sectarian violence.

Such events are not only tragic losses—people dedicating their time to a global health effort senselessly killed—but also they leave children who would have received vaccine unprotected and allow the virus to continue to circulate. The consequences of which can be extremely far reaching: in January, poliovirus related to strains circulating in Pakistan was detected in sewage samples in Cairo, Egypt, more than 3000 km away (the last case of polio in Egypt was recorded in 2004). No new cases of polio have been recorded in Cairo, but health authorities are surveying the impoverished districts of Al Salam and Al Haggana where the virus was found for recent cases of paralysis, and vaccination campaigns have been initiated.

In the middle of the 20th century, children in developed countries of Europe and North America would return to school at the end of the summer break and look around to see empty chairs of classmates who had not returned because they had been crippled or killed by polio. When the global polio eradication initiative (GPEI) was launched in 1988, the disease was endemic in 125 countries and caused paralysis in around 350 000 people every year. Recent events highlight how a threat that for many is thankfully a distant memory—or for younger generations in some developed countries unknown—remains a real and present danger.

The Bill & Melinda Gates Foundation is one of the major contributors of financial aid to the polio eradication effort, and speaking recently in London at the Richard Dimbleby lecture, Bill Gates reiterated his commitment to wiping out the diseases, highlighting the new eradication target of 2018. On January 23, the GPEI published a draft Polio Eradication and Endgame Strategic Plan (2013—18). The plan has four main objectives and four milestones for eradication. The four objectives are, detection and interruption of wild poliovirus, strengthening of routine immunisation and withdrawal of the oral polio vaccine, containment and certification (enabling some facilities to store poliovirus and outlining the processes for certification of eradication), and legacy planning to ensure that resources put aside for polio eradication are repurposed when the goal is achieved. The milestones for the new strategic plan are for the last case of wild polio by 2014, withdrawal of type 2 oral polio vaccine by 2015—16, worldwide certification of polio eradication by the end of 2018, and cessation of bivalent oral polio vaccination during 2019.

This is not the first deadline for polio eradication. When the GPEI was set up, the planned date for eradication was 2000. As the cases become fewer, the problems become knottier, and hindrances to final eradication become ever more dependent on localised factors and characteristics of the virus’s remaining toeholds. As the saying goes, the devil is in the detail.

The new plan encouragingly contains intricate analyses of recent outbreaks in the three remaining countries, reasons for programmatic declines, and reflection on the lessons learned from success in India, which has not recorded a case in more than 2 years. It is an excellent example of how data, local knowledge, and experience can be synthesised to provide clear goals and realistic targets. 2018 seems soon, but for some children it will not be soon enough. And for the vaccination workers who have lost their lives, eradication of polio within 5 years would be a tribute to their efforts.

Source: lancet